After falling from almost $74 a share in June to a low just above $22 a share in December, shares of Crispr Therapeutics $CRSP has been recovering. Looking at the daily chart, it looks like we might have an inverted head and shoulders pattern. Before this week, I was still looking at the bearish outlook for CRSP. But after the bullish breakout, I am looking at a potential price bottom and a potential bullish reversal. Crispr Therapeutics (CRSP) signals Bearish Continuation CRSP Daily Chart (click to enlarge) Price Bottom:- Price has broken above the falling channel resistance and the 100-, and 50-day simple moving averages (SMAs). - The RSI has also pushed above 60 and tagged 70. This shows loss of bearish momentum, and possibly initiation of bullish momentum.- Furthermore, we see strong volume in this week's bullish breakout. Neckline:- Currently, there is a common resistance, or neckline around the $40 level.- If price can close above $40.50 CRSP would be likely in a bullish reversal.- It will still face resistance around $45. Then, if price can hold above the $37-$40 area, we would have more clues for the bullish mode. - The bullish mode has at least the $60 level in sight, with the $74 high in sight as well.